Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 4.39 -2.01% -0.09
VRPX closed down 2.01 percent on Wednesday, July 28, 2021, on 23 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A Down Down
Historical VRPX trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Boomer Buy Setup Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -2.01%
Older End-of-Day Signals for VRPX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 14 hours ago
Up 3% about 16 hours ago
50 DMA Support about 16 hours ago
60 Minute Opening Range Breakout about 16 hours ago
Rose Above 50 DMA about 16 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Virpax Pharmaceuticals, Inc. Description

Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Pain Health Sciences Influenza Drug Delivery Euphoriants Pain Management Dosage Forms Analgesics Morphinans Opioids Drug Delivery Systems Bupivacaine Heroin Post Traumatic Stress Disorder Drug Delivery Technologies Morphine

Is VRPX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.49
52 Week Low 3.7
Average Volume 2,667,525
200-Day Moving Average 0.00
50-Day Moving Average 4.50
20-Day Moving Average 4.87
10-Day Moving Average 4.73
Average True Range 0.97
ADX 65.08
+DI 32.58
-DI 8.17
Chandelier Exit (Long, 3 ATRs) 5.57
Chandelier Exit (Short, 3 ATRs) 6.82
Upper Bollinger Bands 6.28
Lower Bollinger Band 3.47
Percent B (%b) 0.33
BandWidth 57.61
MACD Line 0.00
MACD Signal Line 0.12
MACD Histogram -0.1198
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.01
Resistance 3 (R3) 5.04 4.86 4.90
Resistance 2 (R2) 4.86 4.71 4.85 4.87
Resistance 1 (R1) 4.63 4.61 4.54 4.60 4.83
Pivot Point 4.45 4.45 4.41 4.44 4.45
Support 1 (S1) 4.22 4.30 4.13 4.19 3.95
Support 2 (S2) 4.04 4.20 4.03 3.91
Support 3 (S3) 3.81 4.04 3.88
Support 4 (S4) 3.78